|
|
Article: Update: availability of sulfadiazine - United States. (information about the distribution of drug that treats toxoplasmosis in AIDS patients is now available from Eon Labs Manufacturing instead of the Centers for Disease Control)
- Article from:
- MMWR. Morbidity and Mortality Weekly Report
- Article date:
- September 16, 1994
CopyrightCOPYRIGHT 1994 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Sulfadiazine is commonly used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections. After the domestic commercial supplier of sulfadiazine discontinued marketing the drug in October 1992, CDC temporarily assumed distribution of sulfadiazine under a Food and Drug Administration ...
Related newspaper, magazine, and journal articles:
|
|
Article: Hexal AG Acquires U.S. Generic Manufacturer Eon ...
Business Wire;
December 21, 2000 ;
633 words
... ... has taken over 100% of the New York based Eon Labs Manufacturing, Inc. Eon Labs is one of the fastest growing suppliers of ... Hexal held 50% ownership of the privately run Eon Labs Manufacturing, Inc. On the entire American continent ...
|
|